@FierceBiotech: Cancer immunotherapies in vogue as specialists seek a "cure." Story | Follow @FierceBiotech
@JohnCFierce: NIH is handing out $200M to five institutions for translational med work. Item | Follow @JohnCFierce
> AVEO Pharmaceuticals says it will net slightly more than $100 million on its sale of 5.75 million discounted shares, much of which will be used for its ambitious R&D plans. The developer recently grabbed an impressive $125 million upfront from its partnership with Astellas on tivozanib, a promising experimental cancer drug. Story
> Xconomy reports that the shakeup at iPierian is continuing with the departure of Corey Goodman, its high-profile chairman, and Harvard stem cell expert Doug Melton, a member of the advisory committee. Story
> Stemgent has reportedly now taken in $10.6 million of a $14.1 million Series B. Report
> Qiagen said today that it will acquire France's Ipsogen, a diagnostics company which it values at €70 million. Story
> Meda says it presented positive Phase III data on Dymista, a treatment for allergic rhinitis. Release
Pharma News
@FiercePharma: Laid-off Pfizer reps join OT lawsuit. News | Follow @FiercePharma
> Study: Pfizer, BI inhaler boosts death risk. Report
> Sanofi moves deeper into Genzyme operations. News
> Roche's Herceptin sensitivity test wins FDA nod. Story
> FDA warns Dr Reddy's on Mexico plant's shortfalls. Item
> NC lawsuit shield falters in legislature. Article
Drug Delivery News
> Pfizer, pSivida deal is about big market in patient compliance. Piece
> New delivery system gives Parkinson's patients better quality of life. Article
> Mist inhaler to treat lung disease may not be safe. Report
> UK company looks to move from nutraceuticals to pharmaceuticals. Story
> Nanoparticle delivery into inner ear may help hearing loss. Article
> Singapore scientists design hydrogels that react to pH, temperature. Item
Medical Device News
> Covidien to shake up management structure. News
> Cordis to rein in stent development, cut jobs. Item
> QIAGEN looks to buy Ipsogen. Report
> CerebralRx's FitNes system launched in Europe. Article
> Secant to work with Solvant on biomedical implants. Story
> Spinal Modulation snags $30M in Series D. Report
And Finally... Biotech entrepreneur John Crowley--whose fight to develop a new treatment for Pompe disease to help two of his children became the basis for the movie "Extraordinary Measures"--may run for a Senate seat in New Jersey. Story